Wu P, Nielsen TE. Petasis three-component reactions for the synthesis of diverse heterocyclic scaffolds. Drug Discov Today Technol. 2018;29:27-33. doi:10.1016/j.ddtec.2018.06.010.

Taylor SJ, Taylor AM, Schreiber SL. Synthetic strategy toward skeletal diversity via solid-supported, otherwise unstable reactive intermediates. Angew Chem Int Ed Engl. 2004;43(13):1681-5. doi:10.1002/anie.200353466.

Muncipinto G, Moquist PN, Schreiber SL, Schaus SE. Catalytic diastereoselective petasis reactions. Angew Chem Int Ed Engl. 2011;50(35):8172-5. doi:10.1002/anie.201103271.

Chouraki V, Preis SR, Yang Q, et al. Association of amine biomarkers with incident dementia and Alzheimer’s disease in the Framingham Study. Alzheimers Dement. 2017;13(12):1327-1336. doi:10.1016/j.jalz.2017.04.009.

Wong JC, Sternson SM, Louca JB, Hong R, Schreiber SL. Modular synthesis and preliminary biological evaluation of stereochemically diverse 1,3-dioxanes. Chem Biol. 2004;11(9):1279-91. doi:10.1016/j.chembiol.2004.07.012.

Martyn DC, Ramirez AP, Beattie MJ, et al. Synthesis of spiro-1,2-dioxolanes and their activity against Plasmodium falciparum. Bioorg Med Chem Lett. 2008;18(24):6521-4. doi:10.1016/j.bmcl.2008.10.083.

Nieland TJF, Shaw JT, Jaipuri FA, et al. Identification of the molecular target of small molecule inhibitors of HDL receptor SR-BI activity. Biochemistry. 2008;47(1):460-72. doi:10.1021/bi701277x.

Andresen L, Hampton D, Taylor-Weiner A, et al. Gabapentin attenuates hyperexcitability in the freeze-lesion model of developmental cortical malformation. Neurobiol Dis. 2014;71:305-16. doi:10.1016/j.nbd.2014.08.022.

Legault JT, Strittmatter L, Tardif J, et al. A Metabolic Signature of Mitochondrial Dysfunction Revealed through a Monogenic Form of Leigh Syndrome. Cell Rep. 2015;13(5):981-9. doi:10.1016/j.celrep.2015.09.054.

Qu Z, Krishnamurthy V, Haller CA, et al. Immobilization of actively thromboresistant assemblies on sterile blood-contacting surfaces. Adv Healthc Mater. 2014;3(1):30-5. doi:10.1002/adhm.201300110.